Your browser doesn't support javascript.
loading
Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer.
Palomeras, Sònia; Diaz-Lagares, Ángel; Viñas, Gemma; Setien, Fernando; Ferreira, Humberto J; Oliveras, Glòria; Crujeiras, Ana B; Hernández, Alejandro; Lum, David H; Welm, Alana L; Esteller, Manel; Puig, Teresa.
Afiliação
  • Palomeras S; New Therapeutics Targets Lab (TargetsLab), Department of Medical Sciences, University of Girona, E-17071, Girona, Catalonia, Spain.
  • Diaz-Lagares Á; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
  • Viñas G; Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago(CHUS/SERGAS), CIBERONC, Santiago de Compostela, Spain.
  • Setien F; New Therapeutics Targets Lab (TargetsLab), Department of Medical Sciences, University of Girona, E-17071, Girona, Catalonia, Spain.
  • Ferreira HJ; Medical Oncology Department, Catalan Institute of Oncology (ICO), Girona, Catalonia, Spain.
  • Oliveras G; Girona Biomedical Research Institute (IDIBGI), E-17071, Girona, Catalonia, Spain.
  • Crujeiras AB; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
  • Hernández A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
  • Lum DH; New Therapeutics Targets Lab (TargetsLab), Department of Medical Sciences, University of Girona, E-17071, Girona, Catalonia, Spain.
  • Welm AL; Pathology Department, Dr. Josep Trueta Hospital and Catalan Institute of Health (ICS), E-17071, Girona, Catalonia, Spain.
  • Esteller M; Laboratory of Epigenomics in Endocrinology and Nutrition, Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain.
  • Puig T; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn), Santiago de Compostela, Spain.
Breast Cancer Res ; 21(1): 79, 2019 07 05.
Article em En | MEDLINE | ID: mdl-31277676
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteínas da Matriz Extracelular / Fator de Crescimento Transformador beta / Resistencia a Medicamentos Antineoplásicos / Inativação Gênica / Epigênese Genética / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteínas da Matriz Extracelular / Fator de Crescimento Transformador beta / Resistencia a Medicamentos Antineoplásicos / Inativação Gênica / Epigênese Genética / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article